Synthetic cannabinoid dependence, sustained partial remission

Description

After a diagnosis of synthetic cannabinoid dependence, and often following a treatment episode or other intervention (including self-help intervention), there is a significant reduction in synthetic cannabinoid consumption for more than 12 months, such that even though synthetic cannabinoid use has occurred during this period, the definitional requirements for dependence have not been met.

Index terms

Synthetic cannabinoid dependence, sustained partial remission

Excludes

6C42.0 – Episode of harmful use of synthetic cannabinoids
6C42.1 – Harmful pattern of use of synthetic cannabinoids

Exclusions from above levels

6C41 – Disorders due to use of cannabis
QE62 – Uncomplicated bereavement
QE84 – Acute stress reaction

Sibling codes

6C42.20 – Synthetic cannabinoid dependence, current use
6C42.21 – Synthetic cannabinoid dependence, early full remission
6C42.23 – Synthetic cannabinoid dependence, sustained full remission
6C42.2Y – Other specified synthetic cannabinoid dependence
6C42.2Z – Synthetic cannabinoid dependence, unspecified

Foundation entity

Synthetic cannabinoid dependence, sustained partial remission – http://id.who.int/icd/entity/1253260365

Allowed postcoordination axes

Part of: 6C42.2: Synthetic cannabinoid dependence › 6C42: Disorders due to use of synthetic cannabinoids › 06: Mental, behavioural or neurodevelopmental disorders